Treviso, Italy

Rinaldo Pellegrini


Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Treviso, IT (1986)
  • Carbonera, IT (1986)

Company Filing History:


Years Active: 1986

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Rinaldo Pellegrini: Innovator in Pharmaceutical Chemistry

Introduction

Rinaldo Pellegrini is a notable inventor based in Treviso, Italy. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of new medicinal compounds. With a total of 2 patents to his name, Pellegrini's work focuses on innovative solutions for health-related challenges.

Latest Patents

Pellegrini's latest patents include the use of fenpyramin as a platelet-antiaggregating and vasodilating agent. This patent describes a new application of N-(4'-pyridyl)-3,3-diphenylpropyl amine, known as fenpyramin, as a medicine that inhibits platelet aggregation and serves as an antithrombotic agent, as well as a vasodilating and antianginous medicine. Additionally, he has developed new imidazopyridine derivatives, which are described by a specific chemical formula, where R can represent various chemical groups.

Career Highlights

Pellegrini has established himself as a key figure in the pharmaceutical industry through his innovative research and development efforts. His work has not only advanced scientific understanding but has also contributed to the creation of effective medical treatments.

Collaborations

Throughout his career, Pellegrini has collaborated with esteemed colleagues, including Piero Bellani and Gaetano Clavenna. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.

Conclusion

Rinaldo Pellegrini's contributions to pharmaceutical chemistry exemplify the impact of innovation in medicine. His patents reflect a commitment to improving health outcomes through scientific advancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…